Cytori Therapeutics Inc. (CYTX) financial statements (2021 and earlier)

Company profile

Business Address 4200 MARATHON BLVD.
AUSTIN, TX 78756
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1851013142320
Cash and cash equivalents1851013141516
Short-term investments     85
Restricted cash and investments0010   
Receivables1001114
Inventory, net of allowances, customer advances and progress billings0334454
Inventory0334454
Prepaid expense     2 
Prepaid expense and other current assets5
Other current assets111121 
Other undisclosed current assets     (10)(8)
Total current assets:20101519212225
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment2331221
Intangible assets, net (including goodwill)0101112131313
Goodwill0444444
Intangible assets, net (excluding goodwill) 678999
Restricted cash and investments    000
Other noncurrent assets023222 
Prepaid expense and other noncurrent assets3
Total noncurrent assets:3141716161717
TOTAL ASSETS:23243235383942
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3356766
Accounts payable0111111
Accrued liabilities112232 
Employee-related liabilities111121 
Other undisclosed accounts payable and accrued liabilities1111115
Debt1114147 73
Liabilities of business transferred under contractual arrangement     3 
Other undisclosed current liabilities    206
Total current liabilities:1418181381615
Noncurrent Liabilities
Long-term debt and lease obligation, including:1  11171823
Finance lease, liability0
Operating lease, liability1
Other undisclosed long-term debt and lease obligation   11171823
Liabilities, other than long-term debt0000011
Deferred revenue and credits00011
Contract with customer, liability0
Deferred rent credit 0
Other liabilities0      
Other undisclosed noncurrent liabilities71000100
Total noncurrent liabilities:81011172924
Total liabilities:22191924254439
Stockholders' equity
Stockholders' equity attributable to parent15131112(6)3
Common stock0000000
Additional paid in capital426418413389368332304
Accumulated other comprehensive income 111110
Accumulated deficit(425)(414)(402)(379)(357)(338)(301)
Total stockholders' equity:15131112(6)3
TOTAL LIABILITIES AND EQUITY:23243235383942

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues 435557
Revenue, net  557
Cost of revenue
(Cost of Goods and Services Sold)
 (1)(1)(3)(3)(3)(3)
Other undisclosed gross profit  (1)    
Gross profit: 302224
Operating expenses(11)(17)(25)(28)(24)(37)(39)
Other undisclosed operating income7247735
Operating loss:(4)(13)(21)(20)(15)(32)(31)
Nonoperating income (expense)00(2)(2)(3)(5)5
Investment income, nonoperating0000000
Other nonoperating income (expense) 0000(1)(0)
Interest and debt expense(2)(2)(2)(3)(3)(4)(3)
Loss from continuing operations before equity method investments, income taxes:(5)(15)(25)(25)(22)(42)(30)
Loss from equity method investments      (0)
Loss from continuing operations before income taxes:(5)(15)(25)(25)(22)(42)(30)
Other undisclosed income from continuing operations2      
Loss from continuing operations:(3)(15)(25)(25)(22)(42)(30)
Loss from discontinued operations(8)      
Net loss:(11)(15)(25)(25)(22)(42)(30)
Other undisclosed net income attributable to parent 223343
Net loss attributable to parent:(11)(13)(23)(22)(19)(37)(26)
Preferred stock dividends and other adjustments(1)(2)(4) (1)(1) 
Net loss available to common stockholders, diluted:(11)(15)(27)(22)(19)(39)(26)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(11)(15)(25)(25)(22)(42)(30)
Other comprehensive income    000
Comprehensive loss:(11)(15)(25)(25)(22)(41)(29)
Other undisclosed comprehensive income, net of tax, attributable to parent 223343
Comprehensive loss, net of tax, attributable to parent:(11)(13)(23)(22)(18)(37)(26)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: